Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Long-Term Debt Repayments: 2017-2018

Historic Long-Term Debt Repayments for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $348,000.

  • Astria Therapeutics' Long-Term Debt Repayments fell 58.22% to $348,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $2.8 million, marking a year-over-year decrease of 14.55%. This contributed to the annual value of $2.8 million for FY2018, which is 14.55% down from last year.
  • According to the latest figures from Q4 2018, Astria Therapeutics' Long-Term Debt Repayments is $348,000, which was down 58.22% from $833,000 recorded in Q3 2018.
  • Astria Therapeutics' Long-Term Debt Repayments' 5-year high stood at $834,000 during Q2 2017, with a 5-year trough of $348,000 in Q4 2018.
  • For the 2-year period, Astria Therapeutics' Long-Term Debt Repayments averaged around $772,625, with its median value being $833,000 (2018).
  • Data for Astria Therapeutics' Long-Term Debt Repayments shows a maximum YoY tumbled of 58.22% (in 2018) over the last 5 years.
  • Over the past 2 years, Astria Therapeutics' Long-Term Debt Repayments (Quarterly) stood at $833,000 in 2017, then plummeted by 58.22% to $348,000 in 2018.
  • Its Long-Term Debt Repayments was $348,000 in Q4 2018, compared to $833,000 in Q3 2018 and $834,000 in Q2 2018.